{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:01:18Z","timestamp":1790611278147,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006396","name":"Qazvin University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbr.2019.112359","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:59:25Z","timestamp":1573646365000},"page":"112359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease"],"prefix":"10.1016","volume":"379","author":[{"given":"Mohammad Hossein","family":"Esmaeili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Enayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Khabbaz Abkenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Ebrahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4970-0337","authenticated-orcid":false,"given":"Ali-Akbar","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2019.112359_bib0005","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","article-title":"Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions","volume":"2","author":"Biessels","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbr.2019.112359_bib0010","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/dmrr.1112","article-title":"Cognitive dysfunction in patients with type 2 diabetes","volume":"26","author":"Reijmer","year":"2010","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bbr.2019.112359_bib0015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/WNL.0000000000000269","article-title":"Association of type 2 diabetes with brain atrophy and cognitive impairment","volume":"82","author":"Roberts","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2019.112359_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbr.2019.112359_bib0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbr.2019.112359_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","article-title":"Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer\u2019s disease and diabetes interrelation","volume":"1441","author":"Correia","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnins.2015.00204","article-title":"Aberrant insulin signaling in Alzheimer\u2019s disease: current knowledge","volume":"9","author":"Bedse","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbr.2019.112359_bib0040","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","volume":"19","author":"Crews","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbr.2019.112359_bib0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","article-title":"Diabetes and Alzheimer\u2019s disease crosstalk","volume":"64","author":"Baglietto-Vargas","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2019.112359_bib0050","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.dsx.2016.01.021","article-title":"Shared links between type 2 diabetes mellitus and Alzheimer\u2019s disease: a review","volume":"10","author":"Mittal","year":"2016","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"10.1016\/j.bbr.2019.112359_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"Alzheimer\u2019s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbr.2019.112359_bib0060","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4239\/wjd.v6.i4.598","article-title":"Type 2 diabetes mellitus: from a metabolic disorder to an inflammatory condition","volume":"6","author":"Hameed","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbr.2019.112359_bib0065","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","article-title":"Inflammatory cytokines and Alzheimer\u2019s disease: a review from the perspective of genetic polymorphisms","volume":"32","author":"Su","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bbr.2019.112359_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor \u03b1 and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2019.112359_bib0075","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jcem.86.9.7873","article-title":"Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study","volume":"86","author":"Hak","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","article-title":"Elevated circulating tumor necrosis factor levels in Alzheimer\u2019s disease","volume":"129","author":"Fillit","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbr.2019.112359_bib0085","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbr.2019.112359_bib0090","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","article-title":"Inflammatory pathways and insulin action","volume":"27","author":"Hotamisligil","year":"2003","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbr.2019.112359_bib0095","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bbr.2019.112359_bib0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2019.112359_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1750-1326-6-85","article-title":"Adult hippocampal neurogenesis and its role in Alzheimer\u2019s disease","volume":"6","author":"Mu","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2019.112359_bib0110","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbr.2019.112359_bib0115","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1101\/lm.88005","article-title":"Insulin receptor signaling in long-term memory consolidation following spatial learning","volume":"12","author":"Dou","year":"2005","journal-title":"Learn. Mem."},{"key":"10.1016\/j.bbr.2019.112359_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","article-title":"Role of insulin and insulin receptor in learning and memory","volume":"177","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbr.2019.112359_bib0125","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease\u2013associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2019.112359_bib0130","article-title":"Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2019.112359_bib0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer\u2019s disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0140","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jphp.12148","article-title":"Vildagliptin: an anti\u2010diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin\u2010induced Alzheimer\u2019s disease","volume":"65","author":"Kosaraju","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112359_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112359_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuropharm.2014.07.015","article-title":"Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer\u2019s disease","volume":"86","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2019.112359_bib0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"Metformin attenuates Alzheimer\u2019s disease-like neuropathology in obese, leptin-resistant mice","volume":"101","author":"Li","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2019.112359_bib0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.lfs.2012.08.017","article-title":"Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats","volume":"91","author":"Pintana","year":"2012","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2019.112359_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2018.01.001","article-title":"ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer\u2019s disease","volume":"137","author":"Esmaeili","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2019.112359_bib0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1358\/mf.2004.26.5.831322","article-title":"Reversal of glucose intolerance by pioglitazone in high fat diet-fed rats","volume":"26","author":"Srinivasan","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112359_bib0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12035-015-9132-3","article-title":"Intracerebroventricular streptozotocin injections as a model of Alzheimer\u2019s disease: in search of a relevant mechanism","volume":"53","author":"Grieb","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2019.112359_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00702-012-0877-9","article-title":"What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer\u2019s disease, about the therapeutic strategies in Alzheimer\u2019s research","volume":"120","author":"Salkovic-Petrisic","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2019.112359_bib0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.physbeh.2019.01.005","article-title":"NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease","volume":"202","author":"Amani","year":"2019","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bbr.2019.112359_bib0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"Antidiabetic drugs restore abnormal transport of amyloid-\u03b2 across the blood\u2013brain barrier and memory impairment in db\/db mice","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.bbr.2019.112359_bib0200","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00213-018-5137-8","article-title":"Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease","volume":"236","author":"Amani","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2019.112359_bib0205","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A\u03b2 deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2019.112359_bib0210","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/db09-1163","article-title":"Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study","volume":"59","author":"Marioni","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbr.2019.112359_bib0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2009.11.010","article-title":"Cognitive impairment following high fat diet consumption is associated with brain inflammation","volume":"219","author":"Pistell","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2019.112359_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.05.039","article-title":"Tackling Alzheimer\u2019s disease: hypothetical synergism between anti-inflammatory and anti-diabetic agents","volume":"231","author":"\u0141uc","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bbr.2019.112359_bib0225","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbr.2019.112359_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","article-title":"Inflammation: the link between insulin resistance, obesity and diabetes","volume":"25","author":"Dandona","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbr.2019.112359_bib0235","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000000665","article-title":"Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife","volume":"83","author":"Singh-Manoux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2019.112359_bib0240","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1179\/1743132815Y.0000000015","article-title":"Treadmill exercise is associated with reduction of reactive microgliosis and pro-inflammatory cytokine levels in the hippocampus of type 2 diabetic rats","volume":"37","author":"Yoo","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0245","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","article-title":"Potential role of TNF-\u03b1 in the pathogenesis of insulin resistance and type 2 diabetes","volume":"11","author":"Moller","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0250","series-title":"TNF Pathophysiol","first-page":"145","article-title":"TNF-\u03b1 and obesity","author":"Tzanavari","year":"2010"},{"key":"10.1016\/j.bbr.2019.112359_bib0255","first-page":"E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0260","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2019.112359_bib0265","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1463-1326.2000.00090.x","article-title":"Variations in plasma soluble tumour necrosis factor receptors after diet\u2010induced weight loss in obesity","volume":"2","author":"Bastard","year":"2000","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0270","first-page":"1316","article-title":"No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: fc fusion protein in obese insulin-resistant patients","volume":"85","author":"Paquot","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0275","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diab.45.7.881","article-title":"Effects of an engineered human anti\u2013TNF-\u03b1 antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM","volume":"45","author":"Ofei","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.bbr.2019.112359_bib0280","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1159\/000088261","article-title":"Metabolic and vascular effects of tumor necrosis factor-\u03b1 blockade with etanercept in obese patients with type 2 diabetes","volume":"42","author":"Dominguez","year":"2005","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0285","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/ard.2004.026534","article-title":"Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"64","author":"Kiortsis","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0290","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/156720512799015073","article-title":"Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer\u2019s disease","volume":"9","author":"Tobinick","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2006.11.017","article-title":"Inflammatory processes in Alzheimer\u2019s disease","volume":"184","author":"Heneka","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2019.112359_bib0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-4328(95)00213-8","article-title":"The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer\u2019s disease","volume":"78","author":"Hull","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2012.08.008","article-title":"A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats","volume":"254","author":"Rai","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2019.112359_bib0310","doi-asserted-by":"crossref","first-page":"20518","DOI":"10.1073\/pnas.1014557107","article-title":"Tumor necrosis factor-\u03b1 triggers a cytokine cascade yielding postoperative cognitive decline","volume":"107","author":"Terrando","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbr.2019.112359_bib0315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbr.2003.12.018","article-title":"Cognitive function in young and adult IL (interleukin)-6 deficient mice","volume":"153","author":"Braida","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0320","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":"Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2019.112359_bib0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-4328(00)00180-7","article-title":"Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNF-alpha","volume":"112","author":"Fiore","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0330","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neubiorev.2008.10.005","article-title":"Evidence for a cytokine model of cognitive function","volume":"33","author":"McAfoose","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2019.112359_bib0335","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0197-4580(01)00291-3","article-title":"The role of TNF and its receptors in Alzheimer\u2019s disease","volume":"22","author":"Perry","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2019.112359_bib0340","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: a randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bbr.2019.112359_bib0345","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jcyt.2019.04.054","article-title":"Adalimumab improves cognitive impairment, exerts neuroprotective effects and attenuates neuroinflammation in an A\u03b21-40-injected mouse model of Alzheimer\u2019s disease","volume":"21","author":"Park","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbr.2019.112359_bib0350","doi-asserted-by":"crossref","DOI":"10.1177\/1179573517709278","article-title":"Tumor necrosis factor \u03b1 inhibition for Alzheimer\u2019s disease","volume":"9","author":"Chang","year":"2017","journal-title":"J. Cent. Nerv. Syst. Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0355","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuint.2014.04.001","article-title":"Peripheral administration of an anti-TNF-\u03b1 receptor fusion protein counteracts the amyloid induced elevation of hippocampal TNF-\u03b1 levels and memory deficits in mice","volume":"72","author":"Detrait","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2019.112359_bib0360","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1210\/en.2007-0132","article-title":"Infliximab restores glucose homeostasis in an animal model of diet-induced obesity and diabetes","volume":"148","author":"Araujo","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2019.112359_bib0365","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.bbr.2019.112359_bib0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbr.2017.06.038","article-title":"Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury","volume":"333","author":"Stokum","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2019.112359_bib0375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/jcbfm.2012.166","article-title":"Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia","volume":"33","author":"Ortega","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbr.2019.112359_bib0380","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fnbeh.2016.00156","article-title":"Short-term high-fat diet (HFD) induced anxiety-like behaviors and cognitive impairment are improved with treatment by glyburide","volume":"10","author":"Gainey","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.bbr.2019.112359_bib0385","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2010.05.030","article-title":"Study of the effect of inhibiting galanin in Alzheimer\u2019s disease induced in rats","volume":"641","author":"Baraka","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2019.112359_bib0390","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","article-title":"Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial","volume":"57","author":"Craft","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0395","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0400","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2019.00088","article-title":"Insulin signalling impairment in the brain as a risk factor in Alzheimer\u2019s Disease","volume":"11","author":"H\u00f6lscher","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbr.2019.112359_bib0405","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1350-09.2009","article-title":"Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors","volume":"29","author":"Marks","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2019.112359_bib0410","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-150307","article-title":"Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition","volume":"47","author":"Salameh","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbr.2019.112359_bib0415","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.expneurol.2014.06.004","article-title":"Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces A\u03b2 level and microglia activation in the brains of 3xTg-AD mice","volume":"261","author":"Chen","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbr.2019.112359_bib0420","doi-asserted-by":"crossref","first-page":"45971","DOI":"10.1038\/srep45971","article-title":"Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer\u2019s rat model","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2019.112359_bib0425","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1111\/j.1523-1755.2005.00276.x","article-title":"The ATP-sensitive potassium channel blocker glibenclamide prevents renal ischemia\/reperfusion injury in rats","volume":"67","author":"Pompermayer","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbr.2019.112359_bib0430","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/508409","article-title":"Mechanisms linking inflammation to insulin resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.bbr.2019.112359_bib0435","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/jpet.108.138891","article-title":"Insulin activation of the phosphatidylinositol 3-kinase\/protein kinase B (Akt) pathway reduces lipopolysaccharide-induced inflammation in mice","volume":"326","author":"Kidd","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbr.2019.112359_bib0440","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.1097\/01.CCM.0000282027.10288.10","article-title":"Effect of insulin on the inflammatory and acute phase response after burn injury","volume":"35","author":"Jeschke","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbr.2019.112359_bib0445","first-page":"211","article-title":"Insulin attenuates TNF\u03b1-induced hemopexin mRNA: an anti-inflammatory action of insulin in rat H4IIE hepatoma cells","volume":"9","author":"Franklin","year":"2017","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbr.2019.112359_bib0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2119\/2007-00062.Jeschke","article-title":"Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge","volume":"14","author":"Jeschke","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbr.2019.112359_bib0455","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1038\/s41598-018-29595-0","article-title":"Small litter size impairs spatial memory and increases anxiety-like behavior in a strain-dependent manner in male mice","volume":"8","author":"Salari","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2019.112359_bib0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbi.2015.08.022","article-title":"TNF-\u03b1 from hippocampal microglia induces working memory deficits by acute stress in mice","volume":"55","author":"Ohgidani","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2019.112359_bib0465","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ejphar.2015.09.024","article-title":"Exenatide reduces TNF-\u03b1 expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats","volume":"765","author":"Solmaz","year":"2015","journal-title":"Eur. J. Pharmacol."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819312653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432819312653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:20:52Z","timestamp":1759065652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432819312653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":93,"alternative-id":["S0166432819312653"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112359","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2019.112359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112359"}}